Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.


We performed a global survey of existing deprescribing (tapering) services to identify common practices and inform service development.

Original research | 2023
Clinical guidance, About prescribers, Transitions in care/treatment
Guidelines | 2023
Clinical guidance, Harm reduction, Safer supply, About prescribers

This study explored the use of tiered mentoring opportunities within an ECHO® model to expand treatment capacity and develop a statewide network of medications for OUD (MOUD) expertise.

Original research | 2023
About prescribers, Clinical guidance, Hesitancy of prescribers
Manuel | 2023
le stigmate social, à propos des prescripteurs, les services sociaux, la politique / le cadre de réglementation, les obstacles et les facilitateurs, les guides de pratique clinique
Guide or handbook | 2023
Stigma, About prescribers, Social services, Policy/Regulatory, Barriers and enablers, Clinical guidance
Webpage | 2023
Clinical guidance, Harm reduction, About prescribers
Guidelines | 2015
Clinical guidance, About prescribers

Collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.

Original research | 2023
About PWUD, Clinical guidance
Guidelines | 2023
Clinical guidance, About prescribers, Substitution/OAT
Guide or handbook | 2022
Policy/Regulatory, Clinical guidance

The recent publication of a national guideline and quality standards in Canada have provided clinicians with new, evidence-based recommendations on safe, appropriate opioid use.

Original research | 2022
About prescribers, Clinical guidance, Chronic pain
Rapport | 2022
à propos des pharmaciens, les guides de pratique clinique, l'hésitation des prescripteurs
Commentary | 2022
About prescribers, Policy/Regulatory, Safer supply, Clinical guidance, Hesitancy of prescribers
Guidelines | 2022
Clinical guidance, Safer supply, Policy/Regulatory, About prescribers

This study aimed to determine the feasibility and safety of a tapering dose of lisdexamfetamine for the treatment of acute methamphetamine (MA) withdrawal.

Original research | 2022
Stimulants, Withdrawal, Clinical guidance

We explored whether patients with benzodiazepine exposure at treatment entry would have similar 12-month retention compared to those without benzodiazepine exposure.

Original research | 2022
Substitution/OAT, Clinical guidance

The therapeutic benefits of cannabinoids remain unclear, especially when weighted against their adverse effects.

Lit review | 2022
Withdrawal, Clinical guidance

This review of clinical research reports the evidence regarding biomedical and behavioral treatments for psychostimulant withdrawal symptoms.

Lit review | 2022
Withdrawal, Stimulants, Clinical guidance

Refine Your Search